Immunovant (IMVT) Non-Current Assets (2018 - 2026)
Immunovant (IMVT) recorded Non-Current Assets of $1.31 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 86.4% from $9.68 million a year earlier and down 84.0% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Non-Current Assets (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Immunovant reported Non-Current Assets of $8.2 million, down 4.3% from FY2025.
- Annual Non-Current Assets has a five-year compound annual growth rate of 18.7% (FY2021 to FY2026).
- Across earlier fiscal years, Non-Current Assets came in at $8.56 million in FY2025, $595,000 in FY2024 (-60.5%), $1.51 million in FY2023 (-42.8%) and $2.63 million in FY2022 (-24.4%).
- The fiscal Q1 2027 figure is the lowest quarterly Non-Current Assets since fiscal Q1 2025.
- On a year-over-year basis, Non-Current Assets rose in three of the last five quarters, with growth averaging 153.7%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 833.4% in fiscal Q2 2025, against a decline of 86.4% in fiscal Q1 2027 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $8.2 million (Q4 2026), $9.45 million (Q3 2026) and $9.41 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Immunovant | 7.32 Bn | 4.11 Bn | - | 1.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Mn |
| Mar 31, 2026 | 8.20 Mn |
| Dec 31, 2025 | 9.45 Mn |
| Sep 30, 2025 | 9.41 Mn |
| Jun 30, 2025 | 9.68 Mn |
| Mar 31, 2025 | 8.56 Mn |
| Dec 31, 2024 | 8.39 Mn |
| Sep 30, 2024 | 8.34 Mn |
| Jun 30, 2024 | 631,000.00 |
| Mar 31, 2024 | 595,000.00 |
| Dec 31, 2023 | 670,000.00 |
| Sep 30, 2023 | 893,000.00 |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 1.51 Mn |
| Dec 31, 2022 | 1.82 Mn |
| Sep 30, 2022 | 2.06 Mn |
| Jun 30, 2022 | 2.35 Mn |
| Mar 31, 2022 | 2.63 Mn |
| Dec 31, 2021 | 2.70 Mn |
| Sep 30, 2021 | 2.94 Mn |
API Access
Immunovant Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();